168 related articles for article (PubMed ID: 18315601)
1. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 upregulation during tumor progression in head and neck cancer.
Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
[TBL] [Abstract][Full Text] [Related]
3. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
5. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
[TBL] [Abstract][Full Text] [Related]
6. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
7. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 expression in non-small cell lung carcinoma.
Puglisi F; Minisini AM; Barbone F; Intersimone D; Aprile G; Puppin C; Damante G; Paron I; Tell G; Piga A; Di Loreto C
Cancer Lett; 2004 Aug; 212(2):233-9. PubMed ID: 15279903
[TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
10. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.
Nagy N; Legendre H; Engels O; André S; Kaltner H; Wasano K; Zick Y; Pector JC; Decaestecker C; Gabius HJ; Salmon I; Kiss R
Cancer; 2003 Apr; 97(8):1849-58. PubMed ID: 12673710
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical expression of p21WAF1/Cip1 and Proliferating cell nuclear antigen in laryngeal squamous cell carcinomas.
Li X; Izumaru S; Sakamoto K; Miyajima Y; Nakashima T
J Laryngol Otol; 2006 Dec; 120(12):1042-8. PubMed ID: 16995968
[TBL] [Abstract][Full Text] [Related]
12. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ
Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
[TBL] [Abstract][Full Text] [Related]
13. [Expression of alpha-v integrin subunit in the laryngeal and hypopharyngeal squamous cell carcinomas and its relationship with tumor angiogenesis].
Lu JG; Xiao YL; Kan X; Jin DJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jan; 43(1):46-50. PubMed ID: 18357713
[TBL] [Abstract][Full Text] [Related]
14. Nm23 and cathepsin D expression in laryngeal carcinomas.
Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
[TBL] [Abstract][Full Text] [Related]
15. Galectins as modulators of tumor progression in head and neck squamous cell carcinomas.
Saussez S; Camby I; Toubeau G; Kiss R
Head Neck; 2007 Sep; 29(9):874-84. PubMed ID: 17315170
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
Honjo Y; Inohara H; Akahani S; Yoshii T; Takenaka Y; Yoshida J; Hattori K; Tomiyama Y; Raz A; Kubo T
Clin Cancer Res; 2000 Dec; 6(12):4635-40. PubMed ID: 11156213
[TBL] [Abstract][Full Text] [Related]
17. Tumor risk assessment by means of immunocytochemical detection of early pre-malignant changes in buccal smears.
Bloching MM; Soulsby H; Naumann A; Aust W; Merkel D; Braun T; Naim R
Oncol Rep; 2008 Jun; 19(6):1373-9. PubMed ID: 18497939
[TBL] [Abstract][Full Text] [Related]
18. Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer.
Jeannon JP; Stafford FW; Soames JV; Wilson JA
Otolaryngol Head Neck Surg; 2001 Feb; 124(2):199-202. PubMed ID: 11226957
[TBL] [Abstract][Full Text] [Related]
19. Telomerase catalytic subunit gene expression does not influence survival of patients with squamous cell carcinoma of the larynx and hypopharynx: a case-control study.
Luzar B; Poljak M; Fischinger J; Klopcic U; Gale N
J Laryngol Otol; 2005 Nov; 119(11):917-21. PubMed ID: 16354348
[TBL] [Abstract][Full Text] [Related]
20. [The expression of p21(WAF1/CIP1) and PCNA in hypopharyngeal and laryngeal squamous cell carcinomas].
Li X; Tadashi N; Dong P
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Feb; 19(3):97-9. PubMed ID: 15844604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
